News

Stay Updated! In The World Of Investments!

Sensex 48544.06 660.68 (1.38%)

Glaxosmithkline Phar Latest News

05

Apr, 2021

GlaxosmithKline Pharmaceuticals informs about certificate

In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, GlaxosmithKline Pharmaceuticals has informed that it has enclosed a copy of the Certificate received from Kfintech, the ...

04

Mar, 2021

GlaxoSmithKline Pharmaceuticals informs about newspaper advertisement

Pursuant to Clause 47 of the Listing and Disclosure Requirements Regulations, 2015 LODR) GlaxoSmithKline Pharmaceuticals has informed that it has enclosed the advertisements given in Economic Times, Business Standar...

07

Jan, 2021

Glaxosmithkline Pharmaceuticals informs about board meeting

Glaxosmithkline Pharmaceuticals has informed that the Board of Directors at its meeting held on 7th January 2021 have approved the following changes in Board of Directors of the Company. Raju Krishnasw...

28

Dec, 2020

Glaxosmithkline Pharmaceuticals informs about closure of trading window

Glaxosmithkline Pharmaceuticals has informed that the in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company’s shares is close...

21

Oct, 2020

Glaxosmithkline Pharmaceuticals informs about newspaper publication

Glaxosmithkline Pharmaceuticals has informed that pursuant to clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR), the Company enclosed advertisements given in Economic Times, B...

21

Oct, 2020

Glaxosmithkline Pharmaceuticals informs about compliance certificate

Glaxosmithkline Pharmaceuticals has informed that the Company enclosed copy of the certificate issued by Manish Ghia & Associates, Practicing Company Secretaries, for the period 1st April 2020 to 30th Septem...

18

Sep, 2020

Glaxosmithkline Pharmaceuticals informs about analyst meet

Pursuant to Regulation 30(6) of the Schedule Ill, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed about the details of Analyst or Institutional Me...

01

Jul, 2020

GlaxoSmithKline Pharmaceuticals informs about closure of trading window

GlaxoSmithKline Pharmaceuticals has informed that the in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company's shares is closed from Wednes...

21

May, 2020

GlaxoSmithKline Pharmaceuticals gains on the BSE

GlaxoSmithKline Pharmaceuticals is currently trading at Rs. 1376.45, up by 3.75 points or 0.27% from its previous closing of Rs. 1372.70 on the BSE.

The scrip opened at Rs. 1380.00 ...

21

May, 2020

GlaxoSmithKline Pharmaceuticals to discontinue manufacture, supply of Zinetac tablets

GlaxoSmithKline Pharmaceuticals has decided to discontinue the manufacture and supply of Zinetac tablets (150 mg and 300 mg products) manufactured in India and will in due course request cancellation of the marketing authoriz...

<< First < Previous | 1 | 2 | 3 | 4 | 5 | Next > Last >>

Related Glaxosmithkline Phar Links: Glaxosmithkline Phar Analysis, Glaxosmithkline Phar Reports, Glaxosmithkline Phar Share Price, Healthcare News